In the Press

Guinea Minister of Health and Public Hygiene, Dr. Mamadou Pethe Diallo declared a Lassa fever outbreak in the country after the confirmation of a case in Guéckédou.

Brazzaville/Kinshasa, 23 April 2022 – The health authorities in the Democratic Republic of the Congo today declared an outbreak of Ebola after a case was confirmed in Mbandaka, a city in the north-western Equateur Province. This is the third outbreak in the province since 2018.

A global, Phase 3 trial of approximately 20,000 older adult volunteers for the Bavarian Nordic A/S MVA-BN RSV vaccine candidate began this week and is expected to produce results by mid-2023.

Children conceived with infertility treatment may have a higher risk for asthma and allergies, suggests a study by researchers at the National Institutes of Health. The study was conducted by scientists at the Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Institute of Environmental Health Sciences, part of the National Institutes of Health. It appears in Human Reproduction.

The FDA recently approved the first generic budesonide and formoterol fumarate dihydrate (Symbicort) to treat asthma and chronic obstructive pulmonary disease (COPD).

Eating processed foods can alter the gut microbiome.

An interval of over 10 weeks between COVID-19 vaccine doses was associated with SARS-CoV-2 antibody levels up to 11 times higher than with an interval of 2 to 4 weeks in never-infected participants, according to a preprint paper to be presented at the upcoming annual congress of the European Society of Clinical Microbiology & Infectious Diseases (ESCMID).

Despite being developed to fight the original COVID-19 strain, a third dose of mRNA vaccine boosts the immune system substantially to better fight infections caused by the Omicron variant relative to the standard 2-dose primary series, according to two new studies in Nature and JAMA Network Open.

To determine the susceptibility profiles and the resistome of Pseudomonas aeruginosa isolates from European ICUs during a prospective cohort study (ASPIRE-ICU).